[Diagnosis and treatment of morbus Osler]

Ugeskr Laeger. 2011 Feb 14;173(7):490-5.
[Article in Danish]

Abstract

Morbus Osler or hereditary haemorrhagic telangiectasia (HHT) is a genetic disorder resulting in development of arteriovenous malformations in the mucosa and in visceral organs. The most common symptom is epistaxis. The disease may, however, cause a variety of other serious manifestations such as pulmonary arteriovenous malformations (PAVM), cerebral arteriovenous malformations (CAVM) and gastrointestinal bleeding. Collaboration between various medical specialties is essential in order to provide an up-to-date treatment and thorough work-up in the individual patient. Disregard of symptoms may result in substantial morbidity and may have serious consequences. This overview presents our current understanding of HHT.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Anticoagulants / therapeutic use
  • Arteriovenous Malformations / diagnosis
  • Arteriovenous Malformations / diagnostic imaging
  • Arteriovenous Malformations / pathology
  • Epistaxis / diagnosis
  • Female
  • Humans
  • Interdisciplinary Communication
  • Mucous Membrane / pathology
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / diagnosis
  • Quality of Life
  • Radiography
  • Telangiectasia, Hereditary Hemorrhagic* / diagnosis
  • Telangiectasia, Hereditary Hemorrhagic* / drug therapy
  • Telangiectasia, Hereditary Hemorrhagic* / genetics
  • Telangiectasia, Hereditary Hemorrhagic* / pathology

Substances

  • Anti-Bacterial Agents
  • Anticoagulants